Emily Clayton
Emily Clayton publishes mostly in Infectious Diseases, Pulmonary and Respiratory Medicine and Oncology, on topics such as COVID-19 Clinical Research Studies, Breast Cancer Treatment Studies and SARS-CoV-2 and COVID-19 Research.
- World rank
- #1,102,753 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #88,291 of 367,258
- Works
- 36
- Citations
- 793
- Citations per work
- 22.0
What does Emily Clayton research?
Emily Clayton's work is mostly in Medicine (45%), Biochemistry, Genetics and Molecular Biology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1746.1%
- Health Sciences1644.9%
- Medicine1644.9%
- Life Sciences39.0%
- 1Infectious Diseases20% of their works
- 2Pulmonary and Respiratory Medicine14% of their works
- 3Oncology7% of their works
- 4Cancer Research6% of their works
- 5Surgery4% of their works
- 6Molecular Biology3% of their works
Research topics
Which keywords describe Emily Clayton's research?
The keywords of their largest research topics: ACE2 Receptor, SARS-CoV-2, Epidemiology, Immune Response, Coronavirus, Metastatic Breast Cancer, Vaccine and Clinical Characteristics.
- Therapy Practice
- Porcine Reproductive and Respiratory Syndrome Virus
- Circovirus
- Prostate Cancer
- spike protein
- Gene Expression
- Breast Tumours
- Quality of Life
- Clinical Characteristics
- Metastatic Breast Cancer
- Immune Response
- SARS-CoV-2
- ACE2 Receptor
- Epidemiology
- Coronavirus
- Vaccine
- Thrombosis
- Breast Cancer
- CDK4/6 Inhibitors
- antibody
- Androgen Receptor
- Chemotherapy-Induced Peripheral Neuropathy
- Occupational Science
- Taxanes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- ACE2 Receptor122 topics
- SARS-CoV-2122 topics
- Epidemiology102 topics
- Immune Response102 topics
- Coronavirus82 topics
- Metastatic Breast Cancer82 topics
- Vaccine82 topics
- Clinical Characteristics71 topic
- Thrombosis71 topic
- Quality of Life62 topics
- Breast Cancer51 topic
- Breast Tumours51 topic
- CDK4/6 Inhibitors51 topic
- Gene Expression51 topic
- antibody51 topic
- spike protein51 topic
- Androgen Receptor41 topic
- Prostate Cancer41 topic
- Chemotherapy-Induced Peripheral Neuropathy31 topic
- Circovirus31 topic
- Occupational Science31 topic
- Porcine Reproductive and Respiratory Syndrome Virus31 topic
- Taxanes31 topic
- Therapy Practice31 topic
Where does Emily Clayton work?
Emily Clayton's main affiliation in the publication record is Adelphi Group (United Kingdom), United Kingdom.
How many publications and citations does Emily Clayton have?
OpenAlex counts 36 works and 793 citations for Emily Clayton, an h-index of 12, ranking #1,102,753 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Emily Clayton. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.